Future Market Insights.png
Bipolar Disorder Drugs and Treatment Market to Be Worth US$ 8.1 Billion by the Year 2032 - Comprehensive Research Report by FMI  DUBAI, United Arab Emirates, March 22, 2022 (GLOBE NEWSWIRE) -- The global Bipolar Disorder Drugs And Treatment Market share, which was anticipated to be worth US$5.9 billion in 2022, is expected to...
Webinar Presenter
Developing New Treatments for Mania Using Brain-Based Risk Markers - A Free Webinar from the Brain & Behavior Research Foundation
04 nov. 2021 08h59 HE | Brain & Behavior Research Foundation
New York, Nov. 04, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Developing New Treatments for Mania Using Brain-Based Risk Markers” on...
Former Duke Basketba
Former Duke Basketball Coach McCallie to Address FAU Students
15 juil. 2021 09h02 HE | Florida Atlantic University College of Business
BOCA RATON Fla., July 15, 2021 (GLOBE NEWSWIRE) -- Former Duke University women’s basketball coach Joanne P. McCallie, now an author and advocate for mental health awareness, will speak to students...
OWP_Logo_Primary.png
OWP Pharmaceuticals Announces Patent Issuance for the First-Ever Oral Liquid Suspension of Quetiapine for the Treatment of Schizophrenia and Bipolar Disorder
01 juil. 2021 08h00 HE | OWP Pharmaceuticals, Inc.
NAPERVILLE, Ill., July 01, 2021 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc. is a privately held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and...
22157.jpg
Outlook on the Precision Psychiatry Global Market to 2026 - Increasing Adoption of Inorganic Growth Strategies is Driving Growth
09 avr. 2021 07h58 HE | Research and Markets
Dublin, April 09, 2021 (GLOBE NEWSWIRE) -- The "Global Precision Psychiatry Market: Focus on Product Type, Biomarker, Sample, Technology, Applications, End Users, Country Data (15 Countries), and...
22157.jpg
Global Psychedelic Drugs Markets, 2018-2020 & 2021-2025 - Ketamine, Psilocybin, Ibogaine, LSD, Dimethyltryptamine (DMT), or MDMA
25 mars 2021 07h48 HE | Research and Markets
Dublin, March 25, 2021 (GLOBE NEWSWIRE) -- The "Global Psychedelic Drugs Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)" report has been added to ResearchAndMarkets.com's...
See two people find true love and devotion in ‘Live for Me’
18 févr. 2021 00h00 HE | Archway Publishing
MASON, Ohio, Feb. 18, 2021 (GLOBE NEWSWIRE) -- In Emma Thomas’ new romance novel, “Live for Me” (published by Archway Publishing), the lives of two struggling people collide and take them on a...
Author Explores Bipolar Disorder Through Poetry, Prose in Cathartic Book of Creative Nonfiction
11 janv. 2021 07h00 HE | XlibrisUS
WARRENVILLE, Ill., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Author David Samuelson has published an intimate collection of poetry and prose that sweeps readers up on a trip through the mind of a person...
Author Reflects on Healing Power of Faith in Debut Memoir
16 nov. 2020 07h00 HE | WestBow Press
BROKEN ARROW, Okla., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Author Darrell Hazle has published his debut memoir, which twines his experiences growing in his faith and relationship with God with an...
OWP_Logo_Primary.png
OWP Pharmaceuticals Announces IND Approval for the First-Ever Liquid Oral Suspension Formulation of Quetiapine Fumarate for the Treatment of Schizophrenia and Bipolar Disorder
07 oct. 2020 08h00 HE | OWP Pharmaceuticals
NAPERVILLE, Ill., Oct. 07, 2020 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc. is a privately held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and...